PeerJ Sections


PeerJ, the journal, is now divided into separate Sections by field.

Section Editors have oversight of their section to ensure the journal maintains a fair peer review process and the highest standards of scientific practice in their fields.

Within each Section, the Academic Editors regularly identify and highlight the most important new PeerJ publications in their field. Learn more & Meet the Section Editors.


The mitochondrial genome of Acrobeloides varius (Cephalobomorpha) confirms non-monophyly of Tylenchina (Nematoda)
Jia-Yong Zhang –– This research provide the complete mitochondrial genome of Acrobeloides varius.
Nonalcoholic fatty liver disease, a potential risk factor of non-specific ST-T segment changes: data from a cross-sectional study
David Kennedy –– The growing global burden of non-alcoholic fatty liver disease (NAFLD) and its association with increased risk of cardiovascular events, independent of traditional risk factors, has tremendous clinical significance. The work by Xiao and Co-workers is both timely and highly relevant as it gives insight into risk stratification with a simple clinical tool, the ECG. As such, this study provides useful insights into the cardiovascular risk assessment and management of NAFLD patients.
Analyzing bacterial community in pit mud of Yibin Baijiu in China using high throughput sequencing
Maria del Carmen Portillo –– At present, there is no relevant literature specifically reporting on the bacterial community structure in pit mud of “Yibin Baijiu”. Therefore, the authors selected 13 representative Baijiu enterprises in Yibin, and tried to fully reflect the community characteristics of "Yibin Baijiu" by 16S high-throughput sequencing of a large number of pit mud samples.
Long-term outcomes of repaired and unrepaired truncus arteriosus: 20-year, single-center experience in Thailand
Cheng Zhan –– This manuscript describes a long term experience of the treatment of truncus arteriosus in Thailand.
Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1/AKT/Bcl-2 signalling pathway
Cheng-Chia Yu –– Luteolin administration as novel and natural therapeutic to protect against chemotherapy-induced cardiotoxicity